Literature DB >> 24976177

Surgical management of noncolorectal cancer liver metastases.

Andrew J Page1, Matthew J Weiss, Timothy M Pawlik.   

Abstract

The number of hepatectomies performed for metastatic cancer has dramatically increased over the past 2 decades. Hepatectomy for stage IV colorectal cancer is now considered the standard of care for resectable patients with isolated hepatic disease and acceptable performance status. However, the indications for resection of noncolorectal origin liver metastases are not as clearly defined. This review focuses on emerging data for the resection of noncolorectal metastatic disease to the liver, with a focus on indications for surgical resection. Specifically, we review the current data on the surgical management of nonneuroendocrine and neuroendocrine tumors metastatic to the liver.
© 2014 American Cancer Society.

Entities:  

Keywords:  breast cancer; hepatic metastases; melanoma; neuroendocrine; noncolorectal; renal cell carcinoma; sarcoma

Mesh:

Year:  2014        PMID: 24976177     DOI: 10.1002/cncr.28743

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  Oligometastatic Disease in Pancreatic Cancer - How to Proceed?

Authors:  Bernhard W Renz; Stefan Boeck; Falk Roeder; Christoph Trumm; Volker Heinemann; Jens Werner
Journal:  Visc Med       Date:  2017-02-10

2.  Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients.

Authors:  Kristoffer W Brudvik; Sameer H Patel; Christina L Roland; Claudius Conrad; Keila E Torres; Kelly K Hunt; Janice N Cormier; Barry W Feig; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2015-05-22       Impact factor: 3.452

Review 3.  Contrast-enhanced ultrasound in liver cancer.

Authors:  Simona Leoni; Ilaria Serio; Anna Pecorelli; Sara Marinelli; Luigi Bolondi
Journal:  Hepat Oncol       Date:  2015-01-12

4.  Failure of portal venous embolization. ALPPS as salvage enabling successful resection of bilobar liver metastases.

Authors:  Soumil J Vyas; Neil Davies; Lee Grant; Charles J Imber; Dinesh Sharma; Brian R Davidson; Massimo Malago; Guiseppe Fusai
Journal:  J Gastrointest Cancer       Date:  2014-12

5.  The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis.

Authors:  Georgios A Margonis; Stefan Buettner; Kazunari Sasaki; Yuhree Kim; Francesca Ratti; Nadia Russolillo; Alessandro Ferrero; Nickolas Berger; T Clark Gamblin; George Poultsides; Thuy Tran; Lauren M Postlewait; Shishir Maithel; Alex D Michaels; Todd W Bauer; Hugo Marques; Eduardo Barroso; Luca Aldrighetti; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2016-06-29       Impact factor: 3.647

6.  Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET.

Authors:  Chengjun Sui; Feng Xu; Weifeng Shen; Li Geng; Feng Xie; Binghua Dai; Jiongjiong Lu; Minfeng Zhang; Jiamei Yang
Journal:  Tumour Biol       Date:  2014-11-06

Review 7.  Transarterial Radioembolization Agents: a Review of the Radionuclide Agents and the Carriers.

Authors:  Aysheh Alrfooh; Aditi Patel; Sandeep Laroia
Journal:  Nucl Med Mol Imaging       Date:  2021-07-13

Review 8.  Surgery for oligometastasis of pancreatic cancer.

Authors:  Fengchun Lu; Katherine E Poruk; Matthew J Weiss
Journal:  Chin J Cancer Res       Date:  2015-08       Impact factor: 5.087

9.  Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation.

Authors:  Ali Guner; Taeil Son; In Cho; In Gyu Kwon; Ji Yeong An; Hyoung-Il Kim; Jae-Ho Cheong; Sung Hoon Noh; Woo Jin Hyung
Journal:  Gastric Cancer       Date:  2015-08-01       Impact factor: 7.370

Review 10.  Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature.

Authors:  Flavia Neri; Giorgio Ercolani; Paolo Di Gioia; Massimo Del Gaudio; Antonio Daniele Pinna
Journal:  Updates Surg       Date:  2015-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.